Autologous cord blood mononuclear cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Autologous cord blood mononuclear cells, covering 2021-10-08 to 2023-11-01. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Autologous Cord Blood Mononuclear Cells for Prevention of Bronchopulmonary Dysplasia or Death in Extremely Preterm Neonates [Phase 3]